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Abstract: Several population-based birth cohort studies docu-
mented that 30% of children suffer from wheezing during respira-
tory infections before their third birthday. Infants are prone to
wheeze because of anatomic factors related to the lung and chest
wall in addition to immunologic and molecular influences in com-
parison to older children. Viral infections lead to immunologic
derangements that cause wheezing both in immunocompetent and
immunodeficient infants. Anatomic causes of wheeze may be ex-
trinsic or intrinsic to the airway. Not every wheeze is indicative of
asthma but prediction of asthma in persistent wheezers is possible.
Testing for allergy in these infants is worthwhile and can be of
significant value in avoidable allergens. Treatment of an infant with
wheezing depends on the underlying etiology. Response to bron-
chodilators is unpredictable and a trial of inhaled steroids may be
warranted in a patient who has responded to multiple courses of oral
steroids, has moderate to severe wheezing, or a significant history of
atopy including food allergy or eczema. Ribavirin administered by
aerosol, hyper-immune respiratory syncytial virus immunoglobulin
(RSV IVIG), and intramuscular monoclonal antibody to an RSV
protein have been used for RSV bronchiolitis in infants with con-
genital heart disease or chronic lung disease.
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Wheezing is a high pitched, whistling sound that occurswhen smaller airways are narrowed by presence of
either bronchospasm, swelling of mucosal lining, excessive
amounts of secretions, or inhaled foreign body. It is heard
mostly on expiration as a result of critical airway obstruc-
tion.1 It is polyphonic when there is widespread narrowing of
the airways causing various pitches or levels of obstruction to
airflow as seen in asthma. Monophonic wheezing refers to a
single-pitch sound that is produced in the larger airways
during expiration as in distal tracheomalacia or bronchoma-
lacia. When obstruction occurs in the extrathoracic airways
during inspiration, the noise is referred to as stridor.2
Wheezing is common throughout infancy and child-
hood except in the neonatal period when it is relatively
rare. About 19% of 10-year-old children experience
wheezing with an average age of onset of 3 years.3 In
addition, several population-based birth cohort studies
documented that 30% of children suffer from wheezing
during respiratory infections before their third birthday.
Recurrent wheezing is common, but most patients outgrow
their symptoms by school age.4
Infant wheezing is sometimes mixed with other causes
of noisy breathing including all causes of nasal obstruction in
the first 2 years of life. Adenoid hypertrophy is commonly
miss-diagnosed as bronchospasm on chest auscultation.
PATHOPHYSIOLOGY
Infants are prone to wheezes because of anatomic
factors related to the lung and chest wall in addition to
immunologic and molecular influences in comparison to
older children.5 The obstruction to flow is affected by the
airway caliber and compliance of the infant’s lung. Resis-
tance to airflow through a tube is inversely related to the
radius of the tube to the 4th power. In children 5 years old,
small caliber peripheral airways can contribute up to 50% of
the total airway resistance. Marginal additional narrowing
can cause further flow limitation and a subsequent wheeze.6
With the very compliant newborn chest wall, the inward
pressure produced in expiration subjects the intrathoracic
airways to collapse. Flow limitation is further affected in
infants by the differences in tracheal cartilage composition
and airway smooth muscle tone causing further increase in
airway compliance compared with older children. All of
these mechanisms combine to make the infant more sus-
ceptible to airway collapse, increased resistance, and sub-
sequent wheezing. Many of these conditions are outgrown
by the 1st year of life.7
Immunologic and molecular influences can contribute
to the infant’s propensity to wheeze. In comparison to older
children and adults, infants tend to have higher levels of
lymphocytes and neutrophils, rather than mast cells and
eosinophils in bronchoalveolar lavage fluid. A variety of
inflammatory mediators have also been implicated in the
wheezing infant such as histamine and leukotrienes. Fetal
and/or early postnatal “programming” in which the structure
and function of the lung are affected by factors including fetal
nutrition and fetal and neonatal exposure to maternal smoking
may also occur.8
ETIOLOGY
Congenital conditions causing wheezing disorders
should not be missed and not all wheezy bronchitis is or will
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become asthma.1 Most wheezing in infants is caused by either
inflammation or anatomic abnormalities (Table 1).
Inflammatory Disorders
Infection in Previously Healthy Infants
Bronchiolitis is an acute infectious disease of the lower
respiratory tract that occurs primarily in young infants, most
often in those aged 2–24 months. Seventy-five percent of
cases of bronchiolitis occur in children younger than 1 year,
and 95% in children younger than 2 years. Incidence peaks in
those aged 2–8 months. Annual incidence is 11.4% in infants
younger than 1 year and 6% in those aged 1–2 years. The
illness accounts for 4500 deaths and 90,000 hospital admis-
sions per year. Prevalence may be higher in urban areas.9
Bronchiolitis is usually because of a viral infection of
the small airways. Infection of bronchiolar respiratory and
ciliated epithelial cells produces increased mucus secretion,
cell death, and sloughing, followed by a peribronchiolar
lymphocytic infiltrate and submucosal edema. The combina-
tion of debris and edema produces critical narrowing and
obstruction of small airways. Decreased ventilation of por-
tions of the lung causes ventilation perfusion mismatching,
resulting in hypoxia. During the expiratory phase of respira-
tion, further dynamic narrowing of the airway produces
disproportionate airflow decrease and resultant air trapping.
Work of breathing is increased because of increased end-
expiratory lung volume and decreased lung compliance. Re-
covery of pulmonary epithelial cells occurs after 3–4 days,
but cilia do not regenerate for about 2 weeks. The debris is
cleared by macrophages.2 Infection is spread by direct contact
with respiratory secretions. Previous infection with the com-
mon etiologic viruses does not confer immunity.11
Not all infected infants develop lower respiratory tract
infection (LRTI). Host anatomic and immunologic factors
seem to play a significant role in the severity of the clinical
syndrome. Infants with preexistent smaller airways and di-
minished lung function have a more sever course. In addition,
respiratory syncytial virus (RSV) infection incites a complex
immune response and infants who wheeze express higher
levels of interferon- in the airway and leukotrienes. RSV
coinfection with metapneumovirus can be more severe than
monoifection.12 Human metapneumovirus (hMPV), like hu-
man RSV, is classified in the Pneumovirinae subfamily of the
paramyxoviridae family. However, it is mostly genetically
related to avian metapneumovirus. hMPV was first described
in 2001 by researchers in the Netherlands as a single negative
(stranded RNA) enveloped virus. Two major groups (A and
B) and 4 subgroups have been identified to date.13
There is evidence that deficiencies in antiviral activity
and the integrity of the airway epithelial barrier could make
individuals with asthma more likely to have severe viral
respiratory infections of the lower airway, and thus increase
the risk of exacerbation. Advanced molecular diagnostics
have identified human rhinoviruses (HRVs) as pathogens
frequently causing wheezing illnesses in infants and young
children. Wheezing during HRV infection in early life iden-
tifies children at particularly high-risk of asthma develop-
ment.15 HRV infections promote the expression of factors
that have been associated with airway damage and remodel-
ing such as increased production of mediators involved in
airway remodeling, including amphiregulin, activin A, and
VEGF.16 It was recently demonstrated that HRV infection of
epithelial cells also causes TLR-3 dependent mucin produc-
tion and up-regulation of epidermal growth factor receptor, a
prominent component of epithelial repair.17 Whether partic-
ular strains of HRV are more pathogenic is an open and
important question.15
Infection in Infants With Underlying Disease
The respiratory tract is the organ system most com-
monly involved in immunodeficiency disorders. There is
often a delay in diagnosis and this delay increases the risk of
bronchiectasis and irreversible lung damage occurring before
appropriate treatment is given.18 An immune defect should be
considered in any child who has respiratory infections that are
unusually severe, recurrent, unresponsive to conventional
treatment, or atypical. Common associated features include
TABLE 1. Most Common Causes of Wheezing
by Mechanism
Diagnostic Category Cause
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failure to thrive, which is often secondary to gastrointestinal
disease, severe atopic disease such as eczema, and occasion-
ally, autoimmune disease.19
Selective IgA deficiency is the commonest immunode-
ficiency with an incidence of 1:400–700. Many affected
individuals are asymptomatic, but others, and particularly
those who have an associated IgG subclass or specific anti-
body deficiency, suffer from recurrent sinopulmonary infec-
tions.20 In another important antibody deficiency, X-linked
agammaglobulinemia, pyogenic infections such as pneumo-
nia first seem after 6–12 months. Unless treated with regular
intravenous or subcutaneous immunoglobulin therapy and
aggressive antibiotic treatment of acute infections, this pro-
gresses rapidly to chronic bacterial bronchitis and irreversible
lung damage with bronchiectasis.21
In the past, many cases of childhood bronchiectasis
followed acute lower respiratory tract infections with pertus-
sis, measles, or tuberculosis. This is now rare. Virtually all
children with normal immune function will make a full
recovery from pneumonia or bronchiolitis, even if the acute
episode was severe. However, there are important exceptions
to this rule. Adenovirus serotypes 3, 4, 7, and 21 can all cause
severe bronchiolitis, pneumonia and death. Up to 40–70% of
survivors are left with permanent damage to the airways
(bronchiolitis obliterans) with segmental or lobar atelectasis,
areas of hyperinflation and impaired lung function. A quarter
of children with bronchiolitis obliterans subsequently develop
bronchiectasis.22 Typically, these children are left with
persistent wheeze (which responds poorly to bronchodila-
tors), a persistent cough (which is initially dry but then
becomes productive of purulent sputum), and the charac-
teristic radiologic changes of bronchiolitis obliterans. Sw-
yer-James or MacLoed’s syndrome, where there is a small
hyperlucent lobe with impaired perfusion and ventilation,
has also been described after these infections. Similar
damage can follow severe mycoplasmal pneumonia. Coin-
fection with both adenovirus and Mycoplasma pneumoniae
is particularly devastating.23
Primary ciliary dyskinesia (PCD) may present in new-
born infants with tachypnea or pneumonia, sometimes asso-
ciated with nasal obstruction and a mucopurulent discharge.
In the older infant, it typically presents with a persistent
productive cough, atypical asthma, or occasionally severe
gastro-esophageal reflux, and later with the features of bron-
chiectasis. Half of children with classic Kartagener syndrome
have situs inversus and dextrocardia in addition to PCD and
there is an increased incidence of congenital heart disease,
hydrocephalus and esophageal atresia.24
The Role of Allergy and Asthma
Allergy and asthma are important causes of wheezing
and probably generate the most inquires by the parents of a
wheezing infant. Three identified patterns of infant wheezing
are: the transient early wheezer, 19.9% of the general popu-
lation, had wheezing at least once with a lower respiratory
infection before the age of 3 years but never wheezed again;
the persistent wheezer, 13.7% of the general population, had
wheezing episodes before 3 years and was still wheezing at 6
years; the late onset wheezer, 15% of the general population,
had no wheezing by 3 years, but will wheeze by 6 years. The
other half of children would never wheeze by 6 years. Of all
the infants who wheeze before 3 years old, almost 60% stop
wheezing by 6 years. Risk factors for persistent wheezing
include maternal asthma, maternal smoking, persistent rhini-
tis (apart from acute upper respiratory tract infections), and
eczema at 1 year of age.25
The asthma predictive index (API) was developed 10
years ago by using data from 1246 children in the Tucson
Children’s Respiratory Study birth cohort. It was based on
factors that were found during the first 3 years of life to
predict continued wheezing at school age.26 A loose index
(3 episodes/year and one of the major or 2 of the minor
criteria) and a stringent index (3 episodes/year and one of
the major or 2 of the minor criteria) were created (Fig. 1). The
most impressive aspect of the API is its ability to rule out the
likelihood of asthma by school age in young children with
wheezing.27 For children who are early wheezers during the
first 3 years of life, API negative predictive values ranged
from 93.9% at 6 years of age to 86.5% at 13 years of age. For
children who are early frequent wheezers during the first 3
years of life, the negative predictive values were 91.6 and
84.2% for 6 and 13 years of age, respectively.28
ANATOMIC DISORDERS
Congenital malformations of the respiratory tract
cause wheezing in early infancy. These findings can be
diffuse or focal and can be from an external compression
or an intrinsic abnormality. External vascular compression
includes a vascular ring, in which the trachea and esoph-
agus are surrounded completely by vascular structures, or
a vascular sling, in which the trachea and esophagus are
not completely encircled.30
Laryngomalacia patients typically have high-pitch in-
spiatory stridor that increases with crying and when supine. It
rarely interferes with feeding. Symptoms are usually present
at birth or within the first 4–6 weeks of life and resolves by
How to predict whether an infant with recurrent wheezing or bronchial obstruction 
events will have asthma in the future? 
If a child under the age of three presents with frequent wheezing (> 3 events/years) 
+ 
One major finding or two minor findings 
• If the API is positive, there is a 77% certainty that the patient will have atopic 
asthma at school age 
• If there are no findings and the API is negative, there is a 68% chance that 
wheezing episodes will cease over time and the child will not have atopic asthma 
in the future 
• Children with positive API have 7 times more risk of asthma at school age than 
children with a negative API 
Major Findings:
― Medical diagnosis of eczema in the first 3 years of life 
― At least one parent with a background of asthma 
Minor Findings:
― Medical diagnosis of allergic rhinitis in the first 3 years of life 
― Wheezing not associated with colds in the first 3 years of life 
― Peripheral blood eosinophilia of at least 4% in the first 3 years of life 
FIGURE 1. Assessing the risk of asthma in infants and
school children.
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its own within 18–24 months. Other anomalies include dou-
ble aortic arch, innominate artery compression, aberrant right
subclavian vein, and pulmonary artery sling. Bronchogenic
cysts can also cause extrinsic compression of the trachea.
Tracheomalacia may be observed in association with laryn-
gomalacia or as an isolated lesion. Tracheal stenosis can be a
complication of long-term endotracheal intubation or a con-
genital lesion. Complete tracheal rings are a subset of tracheal
stenosis with severe biphasic airway sounds.31
Recurrent or persistent chest infections are common in
children with congenital abnormalities of the airways, lung
parenchyma, and pulmonary vasculature. For example, re-
peated episodes of pneumonia are often the presenting feature
of lobar sequestration, bronchial stenosis and bronchomala-
cia, and cystic adenomatoid malformations of the lung. Such
an abnormality should be suspected if one lobe is repeatedly
infected or if there is incomplete resolution after treatment.32
Children born with esophageal atresia and tracheo-
esophageal fistula often have repeated episodes of pneumonia
and bronchitis in early life as a result of persisting abnormal-
ities of airway and esophageal function. The condition has an
incidence of 1:3000 and associated vertebral, anal, cardiac,
renal, or limb defect are seen in up to 50% of affected
children. It can cause wheezing with or without direct aspi-
ration into the tracheobronchial tree. Without aspiration, the
reflux is thought to trigger a vagal or neural reflex, causing
increased airway resistance and airway reactivity.33
Cardiovascular causes of wheezing may be related to
dilated chambers of the heart including massive cardiomeg-
aly, left atrial enlargement, and dilated pulmonary arteries.
Pulmonary edema caused by heart failure can also cause
wheezing by lymphatic and bronchial vessel engorgement
that leads to obstruction and edema of the bronchioles and
further obstruction.34
Foreign body aspiration can cause acute or chronic
wheezing. It is estimated that 78% of those who die of foreign
body aspiration are between 2 months and 4 years old. Even
in young infants, a foreign body can be ingested if given to
the infant by another person such as an older sibling. Infants
who have atypical histories or misleading clinical and radio-
logic findings may be misdiagnosed with asthma or another
obstructive disorder as inflammation and granulation develop
around the foreign body. Esophageal foreign body can trans-
mit pressure to the membranous trachea, causing compromise
of the airway lumen.35
Trauma and tumors are much more rare causes of
wheezing in infants. Trauma of any type to the tracheobron-
chial tree can cause an obstruction to airflow. Accidental or
nonaccidental aspirations, burns, or scalds of the tracheobron-




Detailed history laying stress on family history of cystic
fibrosis, immune deficiencies, asthma in a 1st degree relative,
or any other recurrent respiratory condition in children should
be obtained. Social history should include an environmental
history including any smokers at home, number of sibling,
occupation of inhabitants of the home, pets, tuberculosis
exposure, and concerns regarding home environment (eg,
dust mites, construction dust, heating and cooling techniques,
mold, cockroaches).36
On physical examination, evaluation of the patient’s
vital signs with special attention to the respiratory rate and the
pulse oximetry reading for oxygen saturation is an important
initial step. There should also be a thorough review of the
patient’s growth chart for signs of failure to thrive. Biphasic
wheezing can occur if there is a central, large airway obstruc-
tion. The lack of audible wheezing is not reassuring if the
infant shows other signs of respiratory distress because com-
plete obstruction to airflow can eliminate the turbulence,
which causes the sound to resonate. Aeration should be noted
and a trial of a bronchodilator may be warranted to evaluate
for any change in wheezing after treatment. Listening to
breath sounds over the neck will help differentiate upper air
way from lower airway sounds. The absence or presence of
stridor should be noted and appreciated on inspiration. It is
also useful to evaluate the skin of the patient for eczema and
any significant hemangiomas.30 Differential diagnosis of
wheezing according to age is listed in Table 2.
Investigations
Most infants with a first wheezing (even those with
recurrent wheezing) do not need any investigations. The plain
chest x-ray is valuable in assessing the severity and distribu-
tion of lung involvement. Wide-spread changes such as
bronchial wall thickening or inflammation involving several
lobes suggest a systemic disorder such as cystic fibrosis (CF),
ciliary dyskinesia, or an immunodeficiency disorder. Focal
changes are more common if there is congenital abnormality,
TABLE 2. Causes of Wheezing According to Age
Disease Prevalence Neonate/Infant School Age/Adolescent
Common Bronchiolitis Asthma
Asthma
Less Common Pulmonary aspiration Foreign body aspiration
Gastroesophageal reflux Anaphylaxis





Uncommon Congenital heart disease Defective host defenses
Defective host defenses Mediastinal tumors
Immunodeficiency Enlarged mediastinal
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an inhaled foreign body or bronchial obstruction for some
other reason. High resolution computerized tomography
(HRCT) is more sensitive than plain radiographs at revealing
bronchiectasis: it has largely replaced bronchography. It can
also show localized areas of gas-trapping (hyperinflation) and
interstitial fibrosis not evident on the chest x-ray, for example
in children with bronchiolitis obliterans. CT scanning and
magnetic resonance imaging are both helpful for assessing
congenial anatomic abnormalities, such as sequestration or
cystic adenomatoid malformations. Isotope scans provide
useful evidence about regional ventilation and perfusion. All
children with persistent cough should have their sweat elec-
trolytes measured. The sweat test remains the standard diag-
nostic test for CF, although CF gene mutation studies are
being used increasingly. However, the necessity for CF
screening is race-dependent. Other investigations include
bacteriological studies on sputum if this can be produced;
viral and mycoplasmal antibody levels; tuberculin skin test-
ing; and in selected cases, immune function tests. All children
should have a full blood count and white cell differential:
persistent lymphopenia or neutropenia may be present even
when the child is well.37
Treatment
Treatment of an infant with wheezing depends on the
underlying etiology. Response to bronchodilators is unpre-
dictable, regardless of cause, but suggests a component of
bronchial hyperreactivity. It is appropriate to administer al-
buterol aerosol and objectively observe the response. For
infants, it is acceptable to continue to administer inhaled
medications with mask and spacer if a therapeutic benefit is
demonstrated.38 The use of ipratropium bromide is also useful
in infants with significant tracheal and bronchomalacia who
may be made worse by -2 agonists such as albuterol because
of the subsequent decrease in smooth muscle tone.25
A trial of inhaled steroids may be warranted in a patient
who has responded to multiple courses of oral steroids, has
moderate to severe wheezing, or a significant history of atopy
including food allergy or eczema. Inhaled steroids are appro-
priate for maintenance therapy in patients with known reac-
tive airways but are controversial when used for episodic or
acute illnesses.39
Infants with acute bronchiolitis who are experiencing
respiratory distress should be hospitalized; the mainstay of
treatment is supportive. If hypoxemic, the child should re-
ceive cool humidified oxygen. Sedatives are to be avoided
because they may depress respiratory drive.8 Corticosteroids,
whether parenteral, oral, or inhaled, have been used for
bronchiolitis despite conflicting and often negative studies.
Differences of diagnostic criteria, measures of effect, timing
and route of administration, and severity of illness complicate
these studies. Corticosteroids are not recommended in previ-
ously healthy infants with RSV. Ribavirin, an antiviral agent
administered by aerosol, has been used for RSV bronchiolitis
in infants with congenital heart disease or chronic lung
disease.40
Reduction in the severity and incidence of bronchiolitis
because of RSV is possible through the administration of
pooled hyper-immune RSV intravenous immunoglobulin
(RSV-IVIG), and intramuscular monoclonal antibody to the
RVS F protein, before and during RSV season. Palivizumab
is recommended for infants 2 years of age with chronic
lung disease (bronchopulmonary dysplasia) or prematurity.
Meticulous hand washing is the best measure to prevent
nosocomial transmission.12
A practical approach for preschool wheezers was re-
cently proposed. In a preschooler with recurrent wheezing,
the possibility of an underlying allergy should be assessed (by
skin prick testing or determination of specific IgE). If allergy
is not present, the wheezing should be considered as nonal-
lergic (viral-induced wheezing), and usually little mainte-
nance treatment is needed, as most of the children will grow
out of it. Therefore, treatment should be focused on treating
the symptoms (with beta-agonists, short coursed of pred-
nisolone, etc). If the symptoms are frequent a leukotriene-
receptor antagonist might be considered in the first place,
before starting ICS. In contrast, if allergy is present (positive
skin prick test or positive specific IgE) there is an increased
risk that the child will continue wheezing beyond preschool
age. In this case ICS might be necessary to control the
underlying inflammation and to prevent symptoms.41
CONCLUSION
Wheezing in infants could be a sign of diverse clinical
conditions. Meticulous search for the cause and evaluation of
the clinical status are mandatory before conducting therapy.
Not every wheeze is indicative of asthma but prediction of
asthma in persistent wheezers is possible. Testing for allergy
in these infants is worthwhile and can be of significant value
in avoidable allergens. Morbidity may also be diminished and
quality of life improved if controller therapy is started in
proper time.
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